UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Survey of current practices from an international task force for gynecological stereotactic ablative radiotherapy

Radiation oncology (London, England), 2020-01, Vol.15 (1), p.24-24, Article 24

2020

Volltextzugriff (PDF)

EP-1365: Dosimetric predictors for rectal toxicity with two hypofractionated schedules for prostate cancer

Radiotherapy and oncology, 2016-04, Vol.119, p.S637-S637

2016

Volltextzugriff (PDF)

Urethra-sparing SBRT for prostate cancer: dosimetric optimization with VMAT vs. IMRT and the learning curve effect

Radiotherapy and oncology, 2016-02, Vol.118, p.S118-S118

2016

Volltextzugriff (PDF)

Diagnostic utility and therapeutic impact of PET/CT [18F]F-Fluoromethylcholine -Choline in the biochemical recurrence of prostate cancer

Revista Española de medicina nuclear e imagen molecular (English ed.), 2020-09, Vol.39 (5), p.284-291

2020

Volltextzugriff (PDF)

Dose Escalation With 2 Sequential Twice-Weekly Hypofractionated Schedules for Localized Prostate Cancer: A Comparative Study of Long-Term Toxicity and Outcome

International journal of radiation oncology, biology, physics, 2014-09, Vol.90 (1), p.S435-S435

2014

Volltextzugriff (PDF)

Hypofractionated External Beam Radiotherapy to Boost the Prostate with ≥85 Gy/Equivalent Dose for Patients with Localised Disease at High Risk of Lymph Node Involvement: Feasibility, Tolerance and Outcome

Clinical oncology (Royal College of Radiologists (Great Britain)), 2014-06, Vol.26 (6), p.316-322

2014

Volltextzugriff (PDF)

PO-0721: Short vs protracted urethra-sparing prostate SBRT: feasibility and early toxicity from a randomized phase II trial

Radiotherapy and oncology, 2015-04, Vol.115, p.S356-S356

2015

Volltextzugriff (PDF)

Urethra-Sparing Stereotactic Body Radiation Therapy for Localized Prostate Cancer: Dosimetric Results From a Prospective Multicenter Randomized Phase 2 Trial

International journal of radiation oncology, biology, physics, 2014-09, Vol.90 (1), p.S900-S900

2014

Volltextzugriff (PDF)

A Limited Course Of Androgen Deprivation And High Dose Targeted Radiotherapy Of Regional And/or Distant Oligometastatic Recurrences May Prolong Biochemical Free Survival In Prostate Cancer Patients

International journal of radiation oncology, biology, physics, 2011, Vol.81 (2), p.S445-S446

2011

Volltextzugriff (PDF)

PD-0312 DOSE ADAPTED SALVAGE RT AFTER RADICAL PROSTATECTOMY BASED ON AN ERMRI TARGET DEFINITION MODEL: TOXICITY ANALYSIS

Radiotherapy and oncology, 2012-05, Vol.103, p.S123-S124

2012

Volltextzugriff (PDF)

Salvage Radiotherapy after Radical Prostatectomy: Dose-Adapted Treatment to a Target Volume Defined from Typical Patterns of Loco-regional Failure on Endorectal MRI and/or PET-CT

International journal of radiation oncology, biology, physics, 2011, Vol.81 (2), p.S435-S436

2011

Volltextzugriff (PDF)

Uterine sarcomas in breast cancer patients treated with tamoxifen

International journal of gynecological cancer, 2006-03, Vol.16 (2), p.861-865

2006

Volltextzugriff (PDF)

OC-0923 Every-other-day vs once-a-week urethra-sparing prostate SBRT: 5-year results of a randomized trial

Radiotherapy and oncology, 2023-05, Vol.182, p.S769-S770

2023

Volltextzugriff (PDF)

EP-1554 Twice vs thrice-weekly moderate hypofractionated EBRT for PCa: does overall treatment time matter?

Radiotherapy and oncology, 2019-04, Vol.133, p.S839-S839

2019

Volltextzugriff (PDF)

PD-0061: Does the dose to penile bulb/internal pudendal arteries matter for erectile dysfunction post-SBRT?

Radiotherapy and oncology, 2020-11, Vol.152, p.S25-S25

2020

Volltextzugriff (PDF)

Changes on the fluence maps and DVH after three weeks of radiotherapy in a head and neck cancer patient

Radiotherapy and oncology, 2007, Vol.82, p.S50-S51

2007

Volltextzugriff (PDF)

EP-1346: Oligorecurrent nodal prostate cancer: long-term results of an elective nodal irradiation approach

Radiotherapy and oncology, 2017-05, Vol.123, p.S722-S722

2017

Volltextzugriff (PDF)

OC-0503: Weekly vs. every-other-day prostate cancer SBRT: 18-months results from a randomized phase II trial

Radiotherapy and oncology, 2018-04, Vol.127, p.S260-S260

2018

Volltextzugriff (PDF)

Uterine sarcomas in breast cancer patients treated with tamoxifen

International journal of gynecological cancer, 2006-03, Vol.16 (2), p.861-865

2006

Volltextzugriff (PDF)

243 - Urethra-sparing SBRT for prostate cancer: dosimetric optimization with VMAT vs. IMRT and the learning curve effect

Radiotherapy and oncology, 2016-02, Vol.118, p.S118-S118

2016

Volltextzugriff (PDF)

An International Radiosurgery Consortium Survey for Gynecological Stereotactic Ablative Radiation Therapy

International journal of radiation oncology, biology, physics, 2017-10, Vol.99 (2), p.E300-E300

2017

Volltextzugriff (PDF)

OC-0609 Urethra-sparing SBRT for prostate cancer: quality assurance of a randomized phase II trial

Radiotherapy and oncology, 2019-04, Vol.133, p.S321-S322

2019

Volltextzugriff (PDF)

Diagnostic utility and therapeutic impact of PET/CT [18F]F-fluoromethylcholine in the biochemical recurrence of prostate cancer

Revista Española de medicina nuclear e imagen molecular (English ed.), 2020-09, Vol.39 (5), p.284-291

2020

Volltextzugriff (PDF)

11C-Choline PET/CT in the primary diagnosis of prostate cancer: impact on treatment planning

The quarterly journal of nuclear medicine and molecular imaging, 2015-09, Vol.59 (3), p.342

2015

Volltextzugriff (PDF)

EP-1126 HYPOFRACTIONATED BOOST TO THE PROSTATE AFTER WHOLE PELVIS RADIOTHERAPY FOR PATIENTS WITH HIGH-RISK PROSTATE CANCER

Radiotherapy and oncology, 2012-05, Vol.103, p.S434-S434

2012

Volltextzugriff (PDF)

1 – 25 von 306

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(288)
Mit Volltextzugriff
(273)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(153)
Life Sciences & Biomedicine
(132)
Animals
(115)
Humans
(90)
Mice
(88)
Biological And Medical Sciences
(58)
Biochemistry & Molecular Biology
(52)
Oncology
(49)
Keratins - Genetics
(43)
Fundamental And Applied Biological Sciences. Psychology
(40)
Cell Biology
(39)
Mice, Transgenic
(39)
Male
(38)
Female
(34)
Cattle
(29)
Gene Expression
(27)
Molecular And Cellular Biology
(27)
Cells, Cultured
(26)
Keratinocytes - Cytology
(26)
Skin
(25)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Survey of current practices from an international task force for gynecological stereotactic ablative radiotherapy

EP-1365: Dosimetric predictors for rectal toxicity with two hypofractionated schedules for prostate cancer

Urethra-sparing SBRT for prostate cancer: dosimetric optimization with VMAT vs. IMRT and the learning curve effect

Diagnostic utility and therapeutic impact of PET/CT [18F]F-Fluoromethylcholine -Choline in the biochemical recurrence of prostate cancer

Dose Escalation With 2 Sequential Twice-Weekly Hypofractionated Schedules for Localized Prostate Cancer: A Comparative Study of Long-Term Toxicity and Outcome

Hypofractionated External Beam Radiotherapy to Boost the Prostate with ≥85 Gy/Equivalent Dose for Patients with Localised Disease at High Risk of Lymph Node Involvement: Feasibility, Tolerance and Outcome

PO-0721: Short vs protracted urethra-sparing prostate SBRT: feasibility and early toxicity from a randomized phase II trial

Urethra-Sparing Stereotactic Body Radiation Therapy for Localized Prostate Cancer: Dosimetric Results From a Prospective Multicenter Randomized Phase 2 Trial

A Limited Course Of Androgen Deprivation And High Dose Targeted Radiotherapy Of Regional And/or Distant Oligometastatic Recurrences May Prolong Biochemical Free Survival In Prostate Cancer Patients

PD-0312 DOSE ADAPTED SALVAGE RT AFTER RADICAL PROSTATECTOMY BASED ON AN ERMRI TARGET DEFINITION MODEL: TOXICITY ANALYSIS

Salvage Radiotherapy after Radical Prostatectomy: Dose-Adapted Treatment to a Target Volume Defined from Typical Patterns of Loco-regional Failure on Endorectal MRI and/or PET-CT

Uterine sarcomas in breast cancer patients treated with tamoxifen

OC-0923 Every-other-day vs once-a-week urethra-sparing prostate SBRT: 5-year results of a randomized trial

EP-1554 Twice vs thrice-weekly moderate hypofractionated EBRT for PCa: does overall treatment time matter?

PD-0061: Does the dose to penile bulb/internal pudendal arteries matter for erectile dysfunction post-SBRT?

Changes on the fluence maps and DVH after three weeks of radiotherapy in a head and neck cancer patient

EP-1346: Oligorecurrent nodal prostate cancer: long-term results of an elective nodal irradiation approach

OC-0503: Weekly vs. every-other-day prostate cancer SBRT: 18-months results from a randomized phase II trial

Uterine sarcomas in breast cancer patients treated with tamoxifen

243 - Urethra-sparing SBRT for prostate cancer: dosimetric optimization with VMAT vs. IMRT and the learning curve effect

An International Radiosurgery Consortium Survey for Gynecological Stereotactic Ablative Radiation Therapy

OC-0609 Urethra-sparing SBRT for prostate cancer: quality assurance of a randomized phase II trial

Diagnostic utility and therapeutic impact of PET/CT [18F]F-fluoromethylcholine in the biochemical recurrence of prostate cancer

11C-Choline PET/CT in the primary diagnosis of prostate cancer: impact on treatment planning

EP-1126 HYPOFRACTIONATED BOOST TO THE PROSTATE AFTER WHOLE PELVIS RADIOTHERAPY FOR PATIENTS WITH HIGH-RISK PROSTATE CANCER

Suchergebnisse filtern